You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
23 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) on Tuesday announced approval from Japan's Ministry of Health, Labour and Welfare...
23 December 2025 - Clinical-stage immunotherapeutics company Aqualung Therapeutics announced on Monday that it has received approval from the US Food and Drug Administration (FDA) for a Phase 2a study of ALT-100 mAb as an anti-inflammatory and anti-f...
23 December 2025 - BrioHealth Solutions, a US-based company developing the BrioVAD System, a Left Ventricular Assist Device (LVAD), announced on Monday that the 100th participant has been enrolled in the system's INNOVATE Trial.Launched in late ...
22 December 2025 - Finland-based biopharmaceutical company Faron Pharmaceuticals Ltd (AIM:FARN) (First North:FARON) announced on Monday that it has finalised agreements to initiate the Phase I/II BLAZE trial through a strategic collaboration with The...
22 December 2025 - Global biotechnology company Alvotech S.A. (NASDAQ:ALVO) announced on Monday the European launch of Gobivaz (golimumab), its biosimilar to Simponi (golimumab), also known as AVT05 (prefilled syringe and autoinjector).Gobivaz is the...
22 December 2025 -
Biopharmaceutical company AstraZeneca plc (LSE: AZN; Nasdaq: AZN), together with Daiichi Sankyo, announced on Monday that Enhertu (trastuzumab deruxtecan) has been granted Breakth...
22 December 2025 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Monday that it has entered into a voluntary agreement with the US Administration to lower prescription drug prices and expand patient access, including across it...